Two world leading research reactors join forces to create dual supply of medical isotope iodine-125

McMaster University’s Nuclear Reactor (CAN) and NRG (NL) announced a unique collaboration between the Netherlands and Canada in the field of nuclear medicine.

Working together, these two globally renowned research reactors will provide the world with the highest quality radioiodine (I-125), used for the treatment of prostate and other various types of cancers, at the highest level of reliability.

Read the full press release here.